Viewing Study NCT00277758

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:09 AM
Ignite Modification Date: 2026-05-31 @ 7:07 AM
Study NCT ID: NCT00277758
Status: TERMINATED
Last Update Posted: 2008-03-07
First Post: 2006-01-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I
Sponsor: Weill Medical College of Cornell University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Interleukin-2 View